Beyond clinical trials – The cost saving associated with dapagliflozin use in Portugal hospital clinical practice

Beyond clinical trials – The cost saving associated with dapagliflozin use in Portugal hospital clinical practice

Introduction and objectives: Heart failure (HF) is a clinical syndrome associated with substantial morbidity, mortality, and healthcare costs. Dapagliflozin has proven efficacy in reducing the risk of death and hospitalization in HF patients, regardless of left ventricular ejection fraction (LVEF)....

Full description

Saved in:
Bibliographic Details
Main Authors: Dulce Brito, Cândida Fonseca, Fátima Franco, Vanessa Lopes, Sara Gonçalves, Rui Baptista, Joana Sequeira, Irene Marques, Rita Rego, Joana Pimenta, José Silva-Cardoso, Margarida Lopes, Mário Almeida
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Revista Portuguesa de Cardiologia
Subjects:
Insuficiência cardíaca
iSGLT2
Dapagliflozina
Custos de saúde
Encargos económicos
Hospitalização por IC
Online Access:http://www.sciencedirect.com/science/article/pii/S0870255124002269
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S0870255124002269

Similar Items